Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances

NS Gandhi, RK Tekade, MB Chougule - Journal of Controlled Release, 2014 - Elsevier
Chemotherapeutic agents have certain limitations when it comes to treating cancer, the most
important being severe side effects along with multidrug resistance developed against them …

Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives

Y Cheng, L Zhao, Y Li, T Xu - Chemical Society Reviews, 2011 - pubs.rsc.org
In the past decade, nanomedicine with its promise of improved therapy and diagnostics has
revolutionized conventional health care and medical technology. Dendrimers and dendrimer …

Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery

AK Sharma, A Gothwal, P Kesharwani, H Alsaab… - Drug Discovery …, 2017 - Elsevier
Highlights•Dendrimers are efficient nanocarriers having biomedical and diagnostic
application potentials.•Dendrimers can be efficiently encapsulated with drugs by host–guest …

Dendrimers: emerging polymers for drug-delivery systems

BK Nanjwade, HM Bechra, GK Derkar, FV Manvi… - European Journal of …, 2009 - Elsevier
Dendrimers are new class of polymeric materials. It is generally described as a
macromolecule, which is characterized by its extensively branched 3D structure that …

Drug delivery strategies for poorly water-soluble drugs

A Fahr, X Liu - Expert opinion on drug delivery, 2007 - Taylor & Francis
The drug candidates coming from combinatorial chemistry research and/or the drugs
selected from biologically based high-throughput screening are quite often very lipophilic, as …

[HTML][HTML] Development of lipidoid–siRNA formulations for systemic delivery to the liver

A Akinc, M Goldberg, J Qin, JR Dorkin… - Molecular Therapy, 2009 - cell.com
RNA interference therapeutics afford the potential to silence target gene expression
specifically, thereby blocking production of disease-causing proteins. The development of …

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

R Juliano, MR Alam, V Dixit, H Kang - Nucleic acids research, 2008 - academic.oup.com
The potential use of antisense and siRNA oligonucleotides as therapeutic agents has
elicited a great deal of interest. However, a major issue for oligonucleotide-based …

Folate and folate− PEG− PAMAM Dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice

P Singh, U Gupta, A Asthana, NK Jain - Bioconjugate chemistry, 2008 - ACS Publications
Ligand-mediated targeting of drugs especially in anticancer drug delivery is an effective
approach. Dendrimers, due to unique surface topologies, can be a choice in this context. In …

NMR insights into dendrimer-based host–guest systems

J Hu, T Xu, Y Cheng - Chemical reviews, 2012 - ACS Publications
1. INTRODUCTION The host− guest chemistry was first developed with the discovery of
crown ethers by Pederson in the 1960s. 1, 2 It was found that the cyclic crown ethers are …

Dendrimers in biosensors: Concept and applications

J Satija, VVR Sai, S Mukherji - Journal of Materials Chemistry, 2011 - pubs.rsc.org
The performance of biosensors, ie the sensitivity, specificity, linearity, reusability, chemical
stability, and reproducibility is critically dependent on the biofunctionalization of the sensor …